Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics
How Has the Lung Cancer Surgery Market Evolved in Terms of Size and Value From 2025 to 2029?
The lung cancer surgery market size has grown strongly in recent years. It will grow from $5.07 billion in 2024 to $5.33 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to high smoking prevalence, rising lung cancer incidence, expanding hospital infrastructure, growing insurance coverage, and rising surgeon expertise.
The lung cancer surgery market size is expected to see steady growth in the next few years. It will grow to $6.43 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to the aging global population, the rise in non-small cell lung cancer cases, growing awareness in emerging countries, the surge in robotic surgery platforms, and increasing cancer care investment. Major trends in the forecast period include robotic-assisted thoracic surgery, the use of augmented reality in surgery, 3-dimensional printing for surgical simulation, artificial intelligence for surgical planning, and smart surgical instruments.
Get your free report sample today:
What Are the Dominant Growth Drivers Impacting the Lung Cancer Surgery Market Outlook?
The increasing incidence of lung cancer is expected to propel the growth of the lung cancer surgery market going forward. Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs, which can interfere with normal lung function. The increasing incidence of lung cancer is due to prolonged exposure to air pollution, excellent particulate matter, as these tiny particles can penetrate deep into the lungs, causing inflammation, cellular damage, and mutations that can lead to cancer development. Lung cancer surgery helps reduce the incidence of lung cancer-related deaths by enabling early removal of malignant tumors before they can spread or progress. For instance, in June 2025, according to the Centers for Disease Control and Prevention, a US-based federal government agency, in 2023, lung cancer was responsible for 131,584 deaths in the United States, following 218,893 newly reported cases in 2022. Therefore, the increasing incidence of lung cancer is propelling the growth of the lung cancer surgery market.
Which Market Segment Offers the Most Significant Growth Opportunities in the Lung Cancer Surgery Market?
The lung cancer surgery market covered in this report is segmented –
1) By Type: Minimally Invasive Surgeries
2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction
3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments
4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels
5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users
Subsegments:
1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection
2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery
Which Future-Ready Trends Are Expected to Influence the Lung Cancer Surgery Market?
Major companies operating in the lung cancer surgery market are focusing on developing innovative technologies, such as robotic-assisted surgeries, to enhance surgical precision, reduce recovery time, and improve patient outcomes. Robotic-assisted surgeries refer to minimally invasive procedures performed using robotic systems controlled by surgeons to enhance precision, reduce complications, and improve patient recovery outcomes. For instance, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology company, announced the regulatory clearance of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform offers enhanced reach and stability to access small, hard-to-reach lung nodules, improving the ability to diagnose lung cancer at earlier stages. Its advanced maneuverability and integration with imaging technologies allow for more accurate biopsies while minimizing patient discomfort. It is designed to expand procedural capabilities and streamline workflow; the platform supports greater clinical confidence and consistency across a wider range of bronchoscopic procedures.
Who Are the Dominant Players Contributing Significantly to the Lung Cancer Surgery Market Revenue?
Major companies operating in the lung cancer surgery market are Johnson & Johnson, Medtronic plc, Siemens Healthcare GmbH, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, Varian Medical Systems Inc., Karl Storz SE, Lepu Medical Technology (Beijing) Co. Ltd., Ambu A/S, Accuray Incorporated, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc., AngioDynamics Inc., Ackermann Instrument GmbH, Scanlan International Inc., Sontec Instruments Inc., Covidien LLC
Get the detailed lung cancer surgery market report today
Which Regions Are Expected to Record the Strongest CAGR in the Lung Cancer Surgery Market?
North America was the largest region in the lung cancer surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment